Jewish General Hospital clinical trials
Jewish General Hospital is the lead sponsor of 9 current clinical trials in our Canada register. 4 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Fecal Microbiota Transplantation. The most-studied condition is Breast Cancer.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Jewish General Hospital
9 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Functional Pulmonary Capillary Surface Area in BPA for CTEPH
NCT05719415 · ClinicalTrials.gov ↗ · Hypertension, Pulmonary, Pulmonary Thromboembolisms
|
Not applicable | Recruiting | 2023-03 | Canada |
|
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
NCT04671511 · ClinicalTrials.gov ↗ · Breast Cancer Female, Early-stage Breast Cancer, Lymph Node Metastases
|
Not applicable | Recruiting | 2021-03 | Canada |
|
TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence
NCT04874064 · ClinicalTrials.gov ↗ · Breast Cancer
|
Observational | Recruiting | 2019-12 | Canada |
|
The Impact of Fasting Duration on Quality of Recovery After Cesarean Section
NCT06701929 · ClinicalTrials.gov ↗ · Quality Improvement, Quality of Recovery From Anaesthesia, Cesarean Section
|
Observational | Recruiting | 2025-03 | Canada |
|
18F-FDG PET/CT for Diagnosis of Diabetic Foot Osteomyelitis
NCT07828691 · ClinicalTrials.gov ↗ · Diabetic Foot Infections
|
Observational | Not yet open | 2026-11 | Canada |
|
Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery
NCT05188222 · ClinicalTrials.gov ↗ · Left Ventricular Dysfunction, Quality of Recovery, Right Ventricular Dysfunction
|
Phase 4 | Not yet open | 2025-12 | Canada |
|
FMT in Triple Negative Breast Cancer Guided by ctDNA
NCT07292142 · ClinicalTrials.gov ↗ · Breast Cancer
|
Phase 1/2 | Not yet open | 2026-02 | Canada |
|
Transanal Irrigation for the Management of LARS
NCT05007015 · ClinicalTrials.gov ↗ · Low Anterior Resection Syndrome, Rectal Cancer
|
Not applicable | Active, closed | 2022-01 | Canada |
|
First Level Socio-geriatric Evaluation: ESOGER Databank
NCT04393649 · ClinicalTrials.gov ↗ · COVID, Social Isolation, Anxiety
|
Observational | Active, closed | 2020-04 | Canada |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Jewish General Hospital trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Jewish General Hospital trials
21 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Canada | 9 | 4 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Breast Cancer
Sponsors with the most current trials registered for this condition.
Questions about Jewish General Hospital trials
How many clinical trials does Jewish General Hospital sponsor?
Jewish General Hospital is the lead sponsor of 9 current trials on ClinicalTrials.gov in our Canada register, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.
Are Jewish General Hospital trials recruiting?
Yes. 4 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Jewish General Hospital testing?
Its current trials name 1 drug or biological as interventions. The most frequent are Fecal Microbiota Transplantation (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.